Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.322 EUR | -0.60% | -8.83% | -3.50% |
Apr. 10 | Transgene: presents vaccine results at AACR | CF |
Mar. 28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
Sales 2023 | 7.9M 8.45M | Sales 2024 * | 39.8M 42.58M | Capitalization | 133M 142M |
---|---|---|---|---|---|
Net income 2023 | -22M -23.54M | Net income 2024 * | -13M -13.91M | EV / Sales 2023 | 17.6 x |
Net Debt 2023 | 1.63M 1.74M | Net Debt 2024 * | 16.4M 17.55M | EV / Sales 2024 * | 3.75 x |
P/E ratio 2023 |
-6.23
x | P/E ratio 2024 * |
-9.44
x | Employees | 143 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 34.45% |
Latest transcript on Transgene
1 day | -0.60% | ||
1 week | -8.83% | ||
Current month | +15.96% | ||
1 month | +16.78% | ||
3 months | -1.20% | ||
6 months | -3.50% | ||
Current year | -3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 63 | 22-03-30 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 16-03-31 |
Maud Brandely
CTO | Chief Tech/Sci/R&D Officer | 70 | 16-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 13-06-18 | |
Alain Mérieux
BRD | Director/Board Member | 85 | 90-12-31 |
Director/Board Member | 63 | 04-12-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.322 | -0.60% | 15,316 |
24-04-22 | 1.33 | -3.76% | 43,299 |
24-04-19 | 1.382 | -5.08% | 66,113 |
24-04-18 | 1.456 | -1.62% | 30,683 |
24-04-17 | 1.48 | +2.07% | 44,937 |
Real-time Euronext Paris, April 23, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.50% | 142M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+1.66% | 22.19B | |
-16.16% | 21.33B | |
-6.82% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- TNG Stock